Michael Tanner

Biosketch / Results /

Michael Tanner

Associate Professor, Department of Medicine
Content Dir, Clinical Epidemioology
Co-Dir, Master Scholars Program in Humanistic Med
Dir Ambulatory Care Clerkship BV

Contact Info

Address
462 First Avenue
New York, NY 10016

212/562-5490
Michael.Tanner@nyumc.org

Education

1979 — Residency in Internal Medicine at NYU Medical Center, Residency Training

In type 1 diabetes, adding liraglutide to insulin increased hypoglycemia and hyperglycemia with ketosis
Tanner, Michael. In type 1 diabetes, adding liraglutide to insulin increased hypoglycemia and hyperglycemia with ketosis. Annals of internal medicine. 2016 Dec 20;165(12):JC64-JC64 JC64 (2391512)

Commentary
Tanner, M. Commentary [Note]. Annals of internal medicine. 2016 Dec 20;165(12):JC64- (2395992)

Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulphonylureas increases hypoglycemia
Tanner, Michael. Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulphonylureas increases hypoglycemia. Annals of internal medicine. 2016 Aug 16;165(4):JC20-JC20 JC20 (2243022)

Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes
Tanner, Michael. Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes. Annals of internal medicine. 2015 Sep 15;163(6):JC2-JC2 JC2 (1788912)

Review: In patients with mild hypertension and no CV disease, BP-lowering drugs reduce stroke and mortality
Tanner, Michael. Review: In patients with mild hypertension and no CV disease, BP-lowering drugs reduce stroke and mortality. Annals of internal medicine. 2015 May 19;162(10):JC5-JC5 JC5 (1620382)